Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

James A. Jr. Robinson Insider Profile

4 Followers

James A. Jr. Robinson, Director at Urogen Pharma, holds 8.00K shares in Urogen Pharma (Ticker: URGN), holds 3.43K shares in Eledon Pharmaceuticals (Ticker: ELDN), holds 0.00 shares in Urovant Sciences (Ticker: UROV).

James A. Jr. Robinson's Trading History

URGNUrogen Pharma		Aug 28, 2026DirectorUninformative Buy91.88K$261.76K
ELDNEledon Pharmaceuticals		Jan 16, 2026DirectorUninformative Buy5.93K$9.50K
UROVUrovant Sciences		Mar 31, 2021―Uninformative Sell―$0.00
NEOSNeos Therapeutics		Mar 19, 2021―Uninformative Sell―$0.00
ALKSAlkermes		Apr 05, 2019President & COO,Alkermes, Inc.Uninformative Buy158.35K$200.04K
AGTCApplied Genetic Technologies		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

James A. Jr. Robinson insider profile FAQ

What stocks does James A. Jr. Robinson hold?
James A. Jr. Robinson holds: URGN, ALKS, AGTC, NEOS, ELDN, UROV stocks.
What was James A. Jr. Robinson’s latest transaction?
James A. Jr. Robinson’s latest transaction was an Uninformative Buy of $91.88K.
What is James A. Jr. Robinson's role in Urogen Pharma?
James A. Jr. Robinson's role in Urogen Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.